Functional properties of membrane cofactor protein of complement
- 1 December 1989
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 264 (2) , 581-588
- https://doi.org/10.1042/bj2640581
Abstract
Membrane cofactor protein (MCP or gp45-70) of the complement system is a cofactor for factor I-mediated cleavage of fluid-phase C3b and C3b-like C3, which opens the thioester bond. In the present study the activity of MCP was further characterized. Unexpectedly, in the absence of factor I, MCP stabilized the alternative- and, to a lesser extent, the classical-pathway cell-bound C3 convertases and thereby enhanced C3b deposition. Soluble MCP, if added exogenously, hardly functioned as cofactor for the cleavage of erythrocyte-bound C3b to iC3b; i.e. its activity, compared with the cofactor activity of factor H, was inefficient, since less than 10% of the bound C3b was MCP-sensitive. Further, exogenously added soluble MCP was also a weak cofactor for the cleavage of C3b bound to zymosan. Likewise, factor I, in the presence of cells bearing MCP, cleaved fluid-phase C3b inefficiently. These results imply that MCP has very little extrinsic cofactor activity for factor I. In contrast, exogenously added MCP and factor I mediated efficient cleavage of erythrocyte-bound C3b if the concentration of Nonidet P40 was sufficient to solubilize the cells. Interestingly, soluble MCP and factor I degraded C3b attached to certain solubilized acceptor membrane molecules more readily than others. The cleavage reaction of fluid-phase and cell-bound C3b by soluble MCP and factor I produced iC3b, but no C3c and C3dg. These and prior data indicate that soluble MCP has potent cofactor activity for fluid-phase C3b or C3b bound to solubilized molecules, but acts inefficiently towards C3b on other cells. This functional profile is unique for a C3b/C4b binding protein and, taken together with its wide tissue distribution, suggests an important role for MCP in the regulation of the complement system.This publication has 35 references indexed in Scilit:
- Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.Proceedings of the National Academy of Sciences, 1985
- Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.The Journal of Experimental Medicine, 1984
- Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system.The Journal of Immunology, 1984
- Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.Proceedings of the National Academy of Sciences, 1983
- Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.Proceedings of the National Academy of Sciences, 1983
- C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex.Journal of Biological Chemistry, 1983
- Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.The Journal of Experimental Medicine, 1982
- Limited Chymotryptic Cleavage of Human C4-Binding Protein: Isolation of a Carbohydrate-Containing Core Domain and an Active Fragment1The Journal of Biochemistry, 1982
- Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.The Journal of Immunology, 1982
- A fluorometric method for determination of C3b inactivatorClinica Chimica Acta; International Journal of Clinical Chemistry, 1982